Joincare Pharmaceutical Group Industry Co.,Ltd.

Shanghai Stock Exchange 600380.SS

Joincare Pharmaceutical Group Industry Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 2.28 B

Joincare Pharmaceutical Group Industry Co.,Ltd. Cash and Short-Term Investments is USD 2.28 B for the year ending December 31, 2023, a 5.43% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • Joincare Pharmaceutical Group Industry Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 2.16 B, a 15.29% change year over year.
  • Joincare Pharmaceutical Group Industry Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 1.88 B, a -0.64% change year over year.
  • Joincare Pharmaceutical Group Industry Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 1.89 B, a 17.25% change year over year.
  • Joincare Pharmaceutical Group Industry Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 1.61 B, a -3.64% change year over year.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 600380.SS

Joincare Pharmaceutical Group Industry Co.,Ltd.

CEO Mr. Xiong Yu
IPO Date June 8, 2001
Location China
Headquarters Joincare Pharmaceutical Group Building
Employees 14,365
Sector Health Care
Industries
Description

Joincare Pharmaceutical Group Industry Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and healthcare products primarily in China. The company offers chemical drug preparation products, including respiration, gastroenterology, anti-infection, gonadotropic, and psychiatric products; and traditional chinese drug preparation production, which includes anti-tumor and cold products. It also provides chemical APIs and intermediates; diagnostic reagents and equipment, including autoimmunity multiple detection platform and diagnostic kit for IgM; and healthcare products, which includes American ginseng tea and Jingxin menocare essence. In addition, the company engages in the wholesale and retail of skin care products, cosmetics, and other necessities. It offers its products in various forms, such as hormone tablets, oral liquids, and tablets. The company was founded in 1992 and is headquartered in Shenzhen, China.

Similar companies

600267.SS

Zhejiang Hisun Pharmaceutical Co., Ltd.

USD 1.18

0.49%

600352.SS

Zhejiang Longsheng Group Co.,Ltd

USD 1.33

-0.40%

600329.SS

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

USD 4.21

1.60%

600216.SS

Zhejiang Medicine Co., Ltd.

USD 2.08

1.25%

StockViz Staff

February 1, 2025

Any question? Send us an email